InforSense
Financials
Estimates*
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | - | <1m | - | <1m | - | - | - |
EBITDA | (<1m) | <1m | - | - | - | - | - |
% EBITDA margin | - | 107 % | - | - | - | - | - |
Profit | (<1m) | <1m | (<1m) | <1m | <1m | <1m | (<1m) |
% profit margin | - | 107 % | - | 103 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | £4.0m | Early VC | |
$10.0m | Early VC | ||
N/A | N/A | Acquisition | |
Total Funding | $15.3m |
Recent News about InforSense
EditInforsense is a technology company specializing in data management solutions tailored for scientific research. The company operates in the scientific and research market, providing tools that enhance collaboration and accelerate discoveries. Inforsense serves a diverse range of clients, including academic institutions, pharmaceutical companies, and research organizations. The business model revolves around offering software solutions that streamline data collection, analysis, and sharing, thereby improving the efficiency and effectiveness of scientific research. Inforsense generates revenue through software licensing, subscription fees, and professional services such as training and support.
Keywords: data management, scientific research, collaboration, discoveries, academic institutions, pharmaceutical companies, research organizations, software solutions, efficiency, professional services.